SUN, Boxun. Application and Breakthrough of CRISPR-Cas9 Gene Editing Technology in the Clinical Treatment of Sickle Cell Disease. MedScien, [S. l.], v. 3, n. 6, p. 5762, 2025. DOI: 10.61173/yq8gww73. Disponível em: https://ms.deanfrancis.press/article/view/652. Acesso em: 23 oct. 2026.